Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 4/20 | 0.68 |
| ▸ | CA2 | P00918 | 2/20 | 0.68 |
| ▸ | CA7 | P43166 | 2/20 | 0.68 |
| ▸ | CA9 | Q16790 | 2/20 | 0.68 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.54 |
| ▸ | POLB | P06746 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | RGS12 | O14924 | 2/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.49 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.49 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.49 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.49 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.49 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.49 |
| ▸ | AGER | Q15109 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2717725 | 1.00 | CA1 (0.68) | CA1CA2CA7CA9MAPK1 | |
| SCHEMBL4570490 | 1.00 | CA1 (0.68) | CA1CA2CA7CA9MAPK1 | |
| SCHEMBL38656190 | 0.91 | CA1 (0.57) | CA1CA2CA7CA9MAPK1 | |
| SCHEMBL397022 | 0.88 | CA1 (0.78) | CA1CA2CA7CA9MAPK1 | |
| SCHEMBL9661261 | 0.87 | CA1 (0.66) | CA1CA2CA7CA9MAPK1 | |
| SCHEMBL24180413 | 0.85 | CA1 (0.64) | CA1CA2CA7CA9MAPK1 | |
| SCHEMBL14040676 | 0.85 | CA1 (0.64) | CA1CA2CA7CA9MAPK1 | |
| SCHEMBL21344946 | 0.85 | CA1 (0.64) | CA1CA2CA7CA9MAPK1 | |
| SCHEMBL10511102 | 0.85 | CA1 (0.64) | CA1CA2CA7CA9MAPK1 | |
| SCHEMBL12744230 | 0.85 | CA1 (0.68) | CA1CA2CA7CA9MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024137793-A1 | COMPOSITIONS AND METHODS FOR INHIBITING OXIDATION OF NATURAL OIL BASED COMPOSITION USING AMINOPHENOL ANTIOXIDANT | ECOLAB USA INC. (US) | 2024-06-27 | — | — | WO | disclosed |
| WO-2024054637-A1 | SYNTHETIC LUBRICITY ADDITIVES FOR HYDROCARBON FUELS | ECOLAB USA INC. (US) | 2024-03-14 | — | — | WO | disclosed |
| US-20230399323-A1 | NOVEL COMPOUND, a-SYNUCLEIN AGGREGATE BINDER, AND USE THEREOF | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2023-12-14 | — | — | US | disclosed |
| WO-2020260857-A1 | HYDROXAMATE COMPOUNDS AS ANTAGONISTS OF THE ADENOSINE A2A RECEPTOR | AdoRx Therapeutics Limited (GB) | 2020-12-30 | — | — | WO | disclosed |
| WO-2020223225-A1 | OXYGENATED AROMATIC AMINES AND USE AS ANTIOXIDANTS | ECOLAB USA INC. (US) | 2020-11-05 | — | — | WO | disclosed |
| US-20200339503-A1 | OXYGENATED AROMATIC AMINES AND USE AS ANTIOXIDANTS | ECOLAB USA INC. | 2020-10-29 | — | — | US | disclosed |
| US-20200339880-A1 | OXYGENATED AMINOPHENOL COMPOUNDS AND METHODS FOR PREVENTING MONOMER POLYMERIZATION | ECOLAB USA INC. | 2020-10-29 | — | — | US | disclosed |
| CN-109761987-B | Fused tricyclic azasugar derivative, synthesis method thereof and application thereof in preparation of glycosidase inhibitor | 河北大学 | 2020-05-08 | — | — | CN | disclosed |
| WO-2018137573-A1 | COMPOUNDS | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2018-08-02 | — | — | WO | disclosed |
| US-9726933-B2 | Liquid-crystal displays and liquid-crystalline media having homeotropic alignment | MERCK PATENT GMBH (DE) | 2017-08-08 | — | — | US | disclosed |
| US-20070099924-A1 | Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication | JANSSEN SCIENCES IRELAND UC (IE) | 2007-05-03 | — | — | US | disclosed |
| US-20070099924-A1 | Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication | JANSSEN SCIENCES IRELAND UC (IE) | 2007-05-03 | — | — | US | disclosed |
| US-20070088001-A1 | Silinane compounds as cysteine protease inhibitors | QUEST DIAGNOSTICS INVESTMENTS LLC | 2007-04-19 | — | — | US | disclosed |
| EP-1716158-A2 | SILINANE COMPOUNDS AS CYSTEINE PROTEASE INHIBITORS | Schering Aktiengesellschaft (DE) | 2006-11-02 | — | — | EP | disclosed |
| WO-2005074904-A2 | SILINANE COMPOUNDS AS CYSTEINE PROTEASE INHIBITORS | SCHERING AKTIENGESELLSCHAFT (DE) | 2005-08-18 | — | — | WO | disclosed |
| WO-2005058869-A1 | AMINOBENZIMIDAZOLES AND BENZIMIDAZOLES AS INHIBITORS OF RESPIRATORY SYNCYTIAL VIRUS REPLICATION | TIBOTEC PHARMACEUTICALS LTD. (IE) | 2005-06-30 | — | — | WO | disclosed |
| US-5948770-A | CONTROLLING MAMMAL AND PLANT FUNGI | MERCK & CO., INC. (US) | 1999-09-07 | — | — | US | disclosed |
| EP-0625148-A1 | NOVEL BACCATINE III AND 10-DEACETYL BACCATINE III DERIVATIVES, THEIR PREPARATION, AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | Aventis Pharma S.A. (FR) | 1994-11-23 | — | — | EP | disclosed |
| WO-1993016060-A1 | NOVEL BACCATINE III AND 10-DEACETYL BACCATINE III DERIVATIVES, THEIR PREPARATION, AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | RHONE-POULENC RORER S.A. (FR) | 1993-08-19 | — | — | WO | disclosed |
| EP-0322862-A2 | Optically active compounds, their preparation and their use in liquid crystal compositions and liquid crystal optical modulators | HITACHI, LTD. (JP) | 1989-07-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200339503-A1 | OXYGENATED AROMATIC AMINES AND USE AS ANTIOXIDANTS | AOC2, AOX1, COMT | CA1 3363/4885CA2 2456/4885CA7 2530/4885 |
| US-20070099924-A1 | Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, H1-2, H1-4 | CA1 3484/4885CA2 805/4885CA7 2227/4885 |
| US-20230399323-A1 | NOVEL COMPOUND, a-SYNUCLEIN AGGREGATE BINDER, AND USE THEREOF | SNCA, PARK7, ATXN2L | CA1 3364/4885CA2 3080/4885CA7 4118/4885 |
| US-20200339880-A1 | OXYGENATED AMINOPHENOL COMPOUNDS AND METHODS FOR PREVENTING MONOMER POLYMERIZATION | HPD, DNPEP, PAH | CA1 1585/4885CA2 2200/4885CA7 1975/4885 |
| US-20070088001-A1 | Silinane compounds as cysteine protease inhibitors | CTSV, CTSB, CTSS | CA1 1307/4885CA2 1408/4885CA7 1290/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.